BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 14671214)

  • 1. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
    Oyama K; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas.
    Dieterich KD; Gundelfinger ED; Lüdecke DK; Lehnert H
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3327-31. PubMed ID: 9745449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretagogue receptor expression in human pituitary tumors.
    Skinner MM; Nass R; Lopes B; Laws ER; Thorner MO
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4314-20. PubMed ID: 9851770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
    Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
    Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
    de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
    Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.
    Greenman Y; Melmed S
    J Clin Endocrinol Metab; 1994 Sep; 79(3):724-9. PubMed ID: 7521350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
    de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
    J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
    Teshima T; Hara Y; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.